ID
40755
Beschrijving
Study ID: 101468/218 Clinical Study ID: SKF-101468/218 Study Title:A Single-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre, Phase IIa Study to Determine the Pharmacokinetics and Tolerability of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome
Trefwoorden
Versies (1)
- 08-05-20 08-05-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
8 mei 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Pharmacokinetics and Tolerability of Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/218
PK Blood Sampling
- StudyEvent: ODM
Similar models
PK Blood Sampling
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C3174092 (UMLS CUI [2,1])
C0439659 (UMLS CUI [2,2])
C0031327 (UMLS CUI [1,2])
C0011008 (UMLS CUI [2])
C0031327 (UMLS CUI [1,2])
C0040223 (UMLS CUI [2])
C0031327 (UMLS CUI [1,2])
C0031327 (UMLS CUI [1,2])
C0947611 (UMLS CUI [2])